National Medicines Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 2.40 M
- Company Age 25 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 6.90 Cr
- Revenue Growth %
- Net Worth
- Total Assets %
About National Medicines
National Medicines Private Limited (NMPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 July 1999 and has a history of 25 years and seven months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 2.40 M.
The company has closed loans amounting to ₹6.90 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Anuraag Jain and Kamal Chand serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231TN1999PTC042799
-
Company No.
042799
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Jul 1999
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at National Medicines?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anuraag Jain
|
Additional Director | 20-Nov-2007 | Current |
|
Kamal Chand
|
Director | 23-Mar-2017 | Current |
Financial Performance of National Medicines.
National Medicines Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of National Medicines?
Unlock access to National Medicines's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Tricept Life Sciences Private LimitedKamal Chand is a mutual person
-
Wattyl Pharmachems Private LimitedKamal Chand is a mutual person
-
Tricept Pharmaceuticals Private Limited
Kamal Chand is a mutual person
Charges (Loans)
₹0
₹6.90 Cr
Charges Breakdown by Lending Institutions
- Union Bank Of India : 6.25 Cr
- Citi Bank : 0.65 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Oct 2006 | Union Bank Of India | ₹6.25 Cr | Satisfied |
| 25 Jul 2005 | Citi Bank | ₹6.50 M | Satisfied |
How Many Employees Work at National Medicines?
Unlock and access historical data on people associated with National Medicines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of National Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped National Medicines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
